ロード中...
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease. A triple drug combination of the anti-filarial drugs ivermectin, diethylcarbamazine (DEC) and albendazole (IDA) has been shown to be safe and effective for achieving sustained clearanc...
保存先:
| 出版年: | PLoS Negl Trop Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031952/ https://ncbi.nlm.nih.gov/pubmed/33780481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009294 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|